Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization.
Ikuno, Yasushi
Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. [electronic resource] - American journal of ophthalmology Jan 2010 - 140-6 p. digital
Publication Type: Comparative Study; Journal Article
1879-1891
10.1016/j.ajo.2009.08.008 doi
Aged
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Asian People--ethnology
Bevacizumab
Choroidal Neovascularization--drug therapy
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Injections
Intraocular Pressure
Japan--epidemiology
Middle Aged
Myopia, Degenerative--drug therapy
Photochemotherapy
Retreatment
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Visual Acuity--physiology
Vitreous Body
Women's Health
Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. [electronic resource] - American journal of ophthalmology Jan 2010 - 140-6 p. digital
Publication Type: Comparative Study; Journal Article
1879-1891
10.1016/j.ajo.2009.08.008 doi
Aged
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Asian People--ethnology
Bevacizumab
Choroidal Neovascularization--drug therapy
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Injections
Intraocular Pressure
Japan--epidemiology
Middle Aged
Myopia, Degenerative--drug therapy
Photochemotherapy
Retreatment
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Visual Acuity--physiology
Vitreous Body
Women's Health